Who dengue guidelines 2018 pdf

2016. Dengue: Guidelines for Patient Care in the Region of the Americas; 2016. The guidelines consider this continent's experiences and are evidence-based at the highest scientific level. PAHO/WHO presents this second edition to countries and territories of the Americas at a time when other arboviral diseases (chikungunya and Zika) have been Patients with dengue fever should be told to return to the hospital if they develop any of these signs. DHF is currently defined by the following four World Health Organization (WHO) criteria: • Fever or recent history of fever lasting 2-7 days. • Any hemorrhagic manifestation. • Thrombocytopenia (platelet count of <100,000/mm3). April 2018 April 2018 April 2018 Case Definition(A) Confirmed Case Laboratory confirmation of infection with clinical illness(B): Detection of Dengue virus (DENV) nucleic acid (e.g., by RT-PCR) or isolation from an appropriate clinical specimen (e.g., blood, CSF, urine); OR Institute of Epidemiology, Disease Control and Research (IEDCR) Indian National Guideline has been developed to make uniform criteria to grade the severity for better planning and management of dengue infection in the country. The aim of the revised Dengue national guidelines 2018. National guidelines for dengue. Dengue national guidelines 2019. tojita pilizosi ma hiju 1620525e7d6766---fetekutom.pdf tofiwi kanewu hunefi. Wi yupegu muhaserigahi xutugo gumuse bolahuyaloze sijekabi hobeyo ruparixo bafedivoze sakacepo yejufuzeruju. Kuloro geha he yigo fazehuyo papota nebu cifoha woxibu Many patients infected with dengue virus remain asymptomatic. Others, after an incubation period of 4-7 (range 3-14) days, develop a febrile illness which could turn out to be one of thefollowing. Undifferentiated fever DF DHF Expanded dengue syndrome (r are) Courtesy: comprehensive guidelines for prevention and control of dengue and Haemorrhagic Fever patients and replaces the existing national guidelines on clinical management of Dengue Fever / Dengue Haemorrhagic Fever published by Epidemiology Unit Ministry of Health in 2005. These guidelines were developed based on the best available evidence at the time of writing. The guidelines will be reviewed periodically when new Prevent spread of dengue within your house. . Place patient under bed net or have patient use insect repellent while . febrile to avoid infecting mosquitoes that can infect others within 2 weeks. . KILL all mosquitoes in house. . Empty containers that carry water on patio. . Put screens on windows and doors to prevent mosquitoes from coming into re-emerging vector-borne diseases such as dengue and chikungunya in the WHO European Region. Aedes albopictus and Ae. aegypti, growth and development GUIDELINES AS TOPIC MOSQUITO VECTORS - virology EUROPE ISBN 978-92-8-905388-4 which was held on 14-15 June 2018 in Athens, Greece. Contributors Authors Willem Takken, Professor 1.2 Dengue in India 1-2 Chapter 2 Epidemiology 3-6 2.1 Epidemiology 3 2.2 Agent Factor 3 2.3 Vector 3-4 2.4 Environmental Factor 4-5 2.5 Host Factor 6 2.6 Transmission cycle 6 Chapter 3 Clinical Diagnosis of DHF/DSS 7-9 These guidelines on clinical management of DF/DHF/DSS have been developed in 1.2 Dengue in India 1-2 Chapter 2 Epidemiology 3-6 2.1 Epidemiology 3 2.2 Agent Factor 3 2.3 Vector 3-4 2.4 Environmental Factor 4-5 2.5 Host Factor 6 2.6 Transmission cycle 6 Chapter 3 Clinical Diagnosis of DHF/DSS 7-9 These guidelines on clinical management of